Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee.
James L JanuzziJoseph M GarasicScott E KasnerVickie McDonaldMark C PetrieJonathan SeltzerMichael MauroKevin CroceEllin BermanMichael DeiningerAndreas HochhausJavier Pinilla-IbarzFranck NicoliniDong-Wook KimDaniel J DeAngeloHagop KantarjianJing XuTracey HallShouryadeep SrivastavaDaniel NaranjoJorge CortesPublished in: Journal of hematology & oncology (2022)
This independent adjudication study identified lower AOE rates than previously reported, suggesting earlier overestimation that may inaccurately reflect AOE risk with ponatinib. This trial was registered under ClinicalTrials.gov identifier NCT01207440 on September 23, 2010 ( https://clinicaltrials.gov/ct2/show/NCT01207440 ).